Bangladesh Ziska Pharmaceuticals Lorlatinib / Lorlatinib usage and dosage

Lorlatinib/Lorlatinib is a tyrosine kinase inhibitor. Lorlatinib is a drug used to treat adults with non-small cell lung cancer (NSCLC) that has spread to other parts of the body and is ALK-positive. It is also used to treat other types of cancer. Lorlatinib blocks certain proteins made by the ALK gene. Blocking these proteins stops cancer cells from growing and spreading. Currently, this medicine is produced in Bangladesh, Ziska, and is already on the market with government approval. Ziskar Pharmaceuticals is a large pharmaceutical company in Bangladesh that has been established for 35 years, with stricter quality control and production lines. What is the usage and dosage?

The usual adult dose for non-small cell lung cancer is 100 mg taken orally once daily until disease progression or unacceptable toxicity develops. Take lorlatinib exactly as prescribed by your doctor, follow all directions on the prescription label, and read any medication guides or inserts. Swallow the tablet whole without crushing, chewing or breaking it. Take this medicine at the same time every day with or without food, and do not use broken or cracked tablets. If a patient vomits shortly after taking lorlatinib, do not take another dose until the next scheduled dose. Store medication at room temperature, away from moisture and heat. Do not change your dose or stop taking lorlatinib without your doctor's advice. If a dose is missed, take it as soon as possible, but if the next dose is due within 4 hours, skip the missed dose and do not take two doses at once. Doctors should be informed of all medications the patient is taking while taking lorlatinib. The current factory retail price of generic drugs is 100mg30tablets3 about one thousand. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.